Atara Biotherapeutics
ATRA
ATRA
118 hedge funds and large institutions have $146M invested in Atara Biotherapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 42
24% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 29
51% less capital invested
Capital invested by funds: $298M → $146M (-$152M)
Holders
118
Holding in Top 10
1
Calls
$2.23M
Puts
$37K
Top Buyers
| 1 | +$1.7M | |
| 2 | +$1.61M | |
| 3 | +$1.13M | |
| 4 |
Renaissance Technologies
New York
|
+$1.09M |
| 5 |
BG
Baupost Group
Boston,
Massachusetts
|
+$1.05M |
Top Sellers
| 1 | -$9.17M | |
| 2 | -$3.4M | |
| 3 | -$2.57M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.16M |
| 5 |
Rafferty Asset Management
New York
|
-$2.06M |